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From ROBERT BEAGLEHOLE
Sirs—I welcome your timely and perceptive views on the
prevention and control of the increasing burden of cardiovascular
disease in developing countries.1 Though your comments are
particularly addressed to the problems facing developing
countries, they are also relevant for wealthy countries. Despite
the limited successes in controlling the CVD epidemics in coun-
tries such as Australia, the USA, New Zealand and western
Europe, these epidemics are completely uncontrolled in many
Eastern European countries and CVD are still among the lead-
ing causes of premature death in most wealthy countries.
It is timely to encourage the development of surveillance
systems for the major CVD and especially their risk factors.
Estimates of the global burden of disease will be improved by
these data. The surveillance data are also needed to help coun-
tries develop, implement and evaluate their prevention and
control programmes. Several carefully chosen sentinal sites are
required in each region. Ideally these surveillance sites should
be based on public health training institutions. In most parts of
the world these institutions are vulnerable and need long-term
external support, especially for developing career pathways and
research experience of the junior faculty. Surveillance projects
could usefully connect these institutions to the communities
they serve and to the ministry of health. Critical decisions need
to be made about the choice of risk factors to be measured and
when to include disease endpoints. There is a danger in
overloading new systems and above all the utility of data to
policy and action needs to be demonstrated.2
In terms of programmes and policies, there can be no serious
argument with the need to focus on the population approach to
primary prevention. In an ideal world, with unlimited resources,
covering the full spectrum of preventive strategies would be
useful. But nowhere do we have more than pitiful resources for
prevention. It behoves us to make the best use of these resources.
Working towards environmental change is the logical place to
start. It is difficult to convince our professional clinical colleagues
of the importance of this strategy and our lay constituency needs to
be actively involved in debates on the use of limited resources.
The primary goal is to shift the risk factor distributions towards
the left. Fortunately, we have evidence that this is possible 
and likely to be highly effective in reducing the burden of 
CVD.3 Furthermore, we know that the major risk factors are
qualitatively the same in all regions of the world4 and, that
would serve a useful purpose, one could promote flaws in the
work of John Snow.
Under the heading ‘So, what do we do?’ the editorial cites 
the 53rd World Health Assembly resolution on the need for a
national policy framework. However, the resolution is fully
consistent with principles outlined in several earlier statements,
including the Alma Ata Declaration (1978). Coincident with the
Ottawa Charter (1986), for example, Canada released a policy
framework entitled ‘Achieving Health for All’. According to 
its website, CINDI provides participating countries with such 
a framework.5 Frameworks themselves of course are only a
beginning, and a scientifically sound and managerially feasible
approach is essential in order to transform them into practical
actions.6 While the CINDI network process has been ongoing
for many years (and now includes 24 countries), since 1995, 
the Pan American Health Organization (PAHO/WHO) has been
promoting a similar integrated model for NCD programming
(CARMEN), piloted by Chile. CARMEN differs in emphasis from
CINDI, in the context-appropriate inclusion of diabetes, cervical
cancer and injury prevention, which are important issues for
Latin America and the Caribbean.7,8 Similarly, the Mauritius
project is a member of the INTERHEALTH group of projects,
another supportive network, similar conceptually and linked to
the other networks.9 The first step in all these models is a policy
framework.
The potential of such frameworks for NCD prevention and
control is broader than the editorial suggests: many risk factors
and underlying determinants for coronary heart disease and
stroke are equally applicable to other NCD outcomes. Measures
such as tobacco control, dietary and physical fitness approaches,
education regarding care seeking and even promoting quality of
care where service is already being provided, are scientifically
sound and potentially feasible in many developing countries.
Lessons from the now many CINDI, CARMEN and INTERHEALTH
projects around the world are valuable in helping to find a way
forward in the prevention and control of NCD.
References
1 Ebrahim S, Davey Smith G. Exporting failure: coronary heart disease
and stroke in developing countries. Int J Epidemiol 2001;30:201–05.
2 Murray CJL, Lopez AD (eds). The Global Burden of Disease—Summary.
Geneva: World Health Organization, 1996.
3 The Ottawa Charter for Health Promotion; an international
conference on health promotion. Health Promotion 1986;1:iii–v.
4 Vaartiainen, E, Puska P, Pekkanen J, Tuomilheto J, Jousilahti P. Do
changes in risk factors in Finland explain the changes in ischemic
heart disease mortality? In: Puska P, Tuomilehto J, Nissinen A,
Vartiainen E (eds). The North Karelia Project: 20 Year Results and
Experiences. Helsinki: National Public Health Institute, 195, pp.241–54.
5 Noncommunicable diseases and their control: CINDI programme. http:/
www.who.dk/zoro/inv/cindi01.htm
6 White F. Epidemiology in health promotion: a Canadian perspective.
Bull Pan Am Health Organ 1989;23:384–96.
7 World Health Report 1997. Executive Summary. Geneva: World Health
Organization, 1997.
8 Peruga A. Conjunto de Acciones para la Reducion Multifactorial de 
las Enfermedades non Transmissibles. In: Worldwide Efforts to Improve
Heart Health: a follow up to the Catalonia Declaration selected program
descriptions. Washington: US Department of Health and Human
Services, Centers for Disease Control and Prevention and Health
Promotion, June 1997.
9 Khaltaev NG. INTERHEALTH. In: Worldwide Efforts to Improve Heart
Health: a follow up to the Catalonia Declaration selected program descrip-
tions. Washington: US Department of Health and Human Services,
Centers for Disease Control and Prevention and Health Promotion,
June 1997.
University of Aukland and WHO, Geneva.
Editors’ Response—exporting failure
From SHAH EBRAHIM and GEORGE DAVEY SMITH
Our editorial described the limited effects of comprehensive
cardiovascular disease prevention programmes, widely evaluated
in the developed world, and questioned their relevance to
developing countries.1
Dr Puska complains that we have not read the findings of the
North Karelia study carefully enough. Interpretation of what is
shown by the North Karelia study depends on understanding
the nature of the intervention, the time frame over which
changes were examined, and whether one is primarily interested
in ‘explaining’ the changes observed within North Karelia with-
out reference to other studies examining the same question.
The intervention comprised five arms: health education,
screening, a hypertension programme, ‘intensification of
treatment’ (secondary prevention), and rehabilitation, and as
such, was focused mainly on individuals rather than the
population at large.2 As shown in Table 1 of our editorial, the
reductions in risk factors were, in fact, very similar after 10 years
intervention in the control and intervention communities.1
CHD mortality trends over the period 1969 to 1995 show a
greater decline in North Karelia than the rest of the country, but
the 95% confidence intervals for the slopes overlap.3 An
intriguing pattern of decline is hidden in the overall trend. First,
North Karelia experienced an almost immediate and rapid
decline, a rise and a fall in CHD mortality (1971–1975). Second,
rates of decline were significantly greater in the country as a
whole than in North Karelia (1976–1985). Finally, death rates
tended to approximate to each other (1986–1995). Such trends
do not provide unambiguous support for the hypothesis that
the intervention was effective.
Dr Puska suggests that we have not made the effort to go
through the publications from the North Karelia group. We
have made this effort, but like other readers we end up
somewhat confused. For example one of the original North
Karelia investigators, Jukka Salonen, dissented from the view
held by the more enthusiastic members of the team that a
favourable effect on mortality could be attributed to the inter-
vention.4 Both Dr Puska and Dr White cite a paper5 which
concluded that in Finland ‘changes in risk factors explained
almost all of the decline in mortality from ischaemic heart
disease in the 1970s, but in the 1980s the mortality declined
more than predicted by changes in risk factors’. Obtaining a
greater than expected payback is a remarkable achievement
indeed, but one of the North Karelia project authors on this
paper then went on to co-author a paper stating that ‘temporal
trends in mortality from coronary heart disease are not
adequately explained by the lifestyles of Finnish men and
women’.6 Making the effort to go through the publications
actually leads to increased uncertainty and confusion. We would
suggest that it is precisely those commentators who have not
taken the trouble to read the full range of publications who are
the ones who repeat the glib—and traditional—declaration of
victory that has emanated from some of the less critical
members of the health promotion fraternity.
It is less well known than it should be that the North Karelia
study was one of a family of studies using a similar protocol and
launched by World Health Organization in 1974 called the Com-
prehensive Cardiovascular Community Control Programme
(CCCP).7 These other programmes were run in Hungary, USSR,
Switzerland, Norway, Italy, Yugoslavia and both German
republics. Although the North Karelia project has generated
many more publications than other comparable projects
conducted over the last three decades, these other projects are
worthy of our attention in making a balanced decision about
what does and does not work. We are rather surprised that
neither Dr Puska nor Dr White refer to these.
Most of these CCCP studies did not find their way into
accessible peer-reviewed scientific journals and those that did,
together with other related studies demonstrated methodo-
logical weaknesses and generally rather disappointing findings.8,9
A WHO report on the CCCP studies edited by Dr Puska10
attempted to put a gloss on the effectiveness of the projects that
was not supported when the effort was made to read the tables
actually published in the book. For example in the case of the
Swiss project an increase in antihypertensive therapy in the inter-
vention communities was said not to be ‘reflected in mean blood
pressure levels’. This is something of an under-statement; a
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where the epidemics are fully developed, these risk factors
explain the vast majority of new events of CVD.5
I trust that your editorial encourages a greater attention to
applying the knowledge gained from decades of careful and
productive public health sciences.6 I also hope that the IJE will
devote more of its pages to explorations of the policies and
programmes needed to implement the population approach to
primary prevention.7
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